Evidence map›Paper›PMID 29104638›Full record

ArticleExperimental and therapeutic medicine2017

Caffeoylxanthiazonoside exerts cardioprotective effects during chronic heart failure via inhibition of inflammatory responses in cardiac cells.

Bin Yang, Fei Wang, Huili Cao, Guifang Liu, Yuean Zhang, Ping Yan, Bao Li

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Effects of Enalapril on TLR2/NF-Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bin YangDepartment of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, P.R. China.
Fei WangDepartment of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, P.R. China.
Huili CaoDepartment of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, P.R. China.
Guifang LiuDepartment of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, P.R. China.
Yuean ZhangDepartment of Science and Education, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, P.R. China.
Ping YanDepartment of Biochemistry and Molecular Biology, College of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Bao LiDepartment of Cardiology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Shanxi Cardiovascular Hospital · CNSecond Hospital of Shanxi Medical University · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caffeoylxanthiazonoside (CYT) is an active constituent isolated from the fruit of the

Indexed as

caffeoylxanthiazonosidecardioprotective effectsinflammatory cytokinesnuclear factor-κB pathwayXanthium strumarium L.

Identifiers

PMID29104638
PMCPMC5658723
OpenAlexW2752143510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.